Licensing agreements are reshaping multiple industries right now, from pharma collaborations worth billions to cannabis distribution deals and AI data partnerships. Companies across life sciences, consumer goods, and tech are using exclusive licensing to access new markets, technologies, and revenue streams.
·AlzeCure Pharma and QuantumCell ApS struck a $2.2 billion pharma licensing deal
·Seed Junky Genetics secured exclusive cannabis licensing in Illinois through Echelon Grow
·Roberto Cavalli inked exclusive ceramics licensing with Rak Ceramics for home goods
·METiS TechBio and Boulevard Bio entered global license agreement for T-cell therapy technology
·Reddit faces investor scrutiny over AI data licensing renewal terms and pricing
drawn from Insurance Journal, Pharmaceutical Executive, Greenway Magazine, GlobeNewswire · updated 2d ago